Development and Validation of UV Spectrophotometric Method for Simultaneous Estimation of Quinfamide and Mebendazole in in-house Pharmaceutical Formulation

Home > 2018, Vol. 6 No. 1 > Development and Validation of UV Spectrophotometric Method for Simultaneous Estimation of Quinfamide and Mebendazole in in-house Pharmaceutical Formulation

Published: May 2, 2018

Download PDF

Download XML | Download HTML

Authors

Ajinkya G. DhandarDepartment of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur Distt. Dhule, MH – 425 405, India
Saurabh B. GanorkarDepartment of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur Distt. Dhule, MH – 425 405, India
Amod S. PatilDepartment of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur Distt. Dhule, MH – 425 405, India
Atul A. ShirkhedkarDepartment of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur Distt. Dhule, MH – 425 405, India

DOI Number
https://doi.org/10.15415/jptrm.2018.61002

Keywords
Quinfamide, Mebendazole, Vierodt’s Method and Multi-component Mode, UV-Spectrophotometer, Validation

Abstract

The present work described the development of two simple, accurate, rapid, cost effective and reproducible UV-Spectrophotometric methods for the simultaneous estimation of Quinfamide and Mebendazole in bulk and in laboratory mixture using 0.01M methanolic HCl as a solvent. The absorption maximum for Quinfamide and Mebendazole were found to be at 260.00 nm and 232.40 nm respectively. Beer’s – lamberts was followed in concentration ranges of 1 – 6 μg/mL for Quinfamide and 2- 12 μg/mL for Mebendazole. The percentage recovery of Quinfamide and mebendazole ranged from 98.48 to 99.08 and 98.83 to 99.62 (Method I); from 98.14 to 98.93 and 99.16 to 99.35 (Method II) for Quinfamide and Mebendazole. The established methods were sensible for simultaneous quantitative determination of both these drugs in fixed dose combinations. Validation of both these methods was performed as per ICH guidelines. The developed methods can routinely be used for estimation of both these drugs in their combined dosage form.

References

Gouda, A.A., El-Sayed, M.I., Amin, A.S. and El Sheikh, R., 2013. Spectrophotometric and spectroflurometric methods for the determination of non-steroidal anti inflammatory drugs: A review. Arabian Journal of Chemistry, 6 (2), 145–63. https://doi.org/10.1016/j.arabjc.2010.12.006
Rojas, F. S., Ojeda and C. B., 2009. Recent development in derivative ultraviolet/ visible absorption spectrophotometry, a review. Analytica Chimica Acta, 635 (1), 22–44.
WHO Expert Committee, 1987. Public health significance of intestinal parasitic infections. Bulletin of the World Health Organization, 65 (5), 575.
Assob, J. C., Nsagha, D.S., Njouendou, A. J., Zofou, D., Sevidzem, W. F., Ketchaji, A., Chiara, A., Asangbeng, T. E., Dzemo, K. O., Samba, B. M. and Wenze, A. C., 2017. Diseases in Africa: An Overview. In Medicinal Spices and Vegetables from Africa, 1–69.
Morales, J. M., Jung, C. H., Alarcón, A. and Barreda, A., 2000. Solid-phase extraction and liquid chromatographic quantitation of quinfamide in biological samples. Journal of Chromatography. Biomedical Sciences and Application, 746 (2), 133–9.
Aquino, I., Alcalá, Y., Gutiérrez, L., Tapia, G., Jung, H. and Sumano, H. 2016. In vivo anticoccidial activity of quinfamide in broilers: a preliminary report. Italian Journal of Animal Science, 15 (4), 689–95. https://doi.org/10.1080/1828051X.2016.1229585
Nagarajan K., 2006. Creative research in the chemical industry–Four decades in retrospect. Journal of Chemical Sciences, 118 (4), 291 309. https://doi.org/10.1007/BF02708523
Davila-Gutierrez, C. E., Vasquez, C., Trujillo-Hernandez, B. and Huerta, M., 2002. Nitazoxanide compared with quinfamide and mebendazole in the treatment of helminthic infections and intestinal protozoa in children. The American journal of tropical medicine and hygiene, 66 (3), 251–4. https://doi.org/10.4269/ajtmh.2002.66.251
Padilla, N., Diaz, R., Alarcon, A. and Barreda, R., 2002. Antiamoebic chemoprophylaxis using quinfamide in children: a comparative study. The Scientific World Journal, (2), 1070. https://doi.org/10.1100/tsw.2002.174
Liu, H., Jiang, C., Hui, Y., Shen, X., Zhang, X. and Yu, H. 2010. SPE–LC multiresidue analysis of mebendazole and its metabolites in grass carp and shrimp. Chromatographia, 72(11-12), 1083–8. https://doi.org/10.1365/s10337-010-1768-6
Parakh, D. R., Madagul, J. K., Mene, H. R., Patil, M. P. and Kshirsagar, S. J. 2016. RP-HPLC method development and validation for Quantification of Mebendazole in API and Pharmaceutical Formulations. PharmaTutor, 4(5), 46–51.
Eskandari, M., Yamini, Y., Fotouhi, L. and Seidi, S. 2011. Microextraction of mebendazole across supported liquid membrane forced by pH gradient and electrical field. Journal of pharmaceutical and biomedical analysis, 54(5), 1173–9. https://doi.org/10.1016/j.jpba.2010.12.006
ICH guidelines: Q2(1) Validation of Analytical Procedure : Text and Methodology 1996.

How to Cite

Ajinkya G. Dhandar, Saurabh B. Ganorkar, Amod S. Patil, Atul A. Shirkhedkar. Development and Validation of UV Spectrophotometric Method for Simultaneous Estimation of Quinfamide and Mebendazole in in-house Pharmaceutical Formulation. J. Pharm. Technol. Res. Manag.. 2018, 06, 9-20

Development and Validation of UV Spectrophotometric Method for Simultaneous Estimation of Quinfamide and Mebendazole in in-house Pharmaceutical Formulation

Current Issue

Periodicity	Biannually
Issue-1	May
Issue-2	November
ISSN Print	2321-2217
ISSN Online	2321-2225
RNI No.	CHAENG/2013/50088

OA Policy

Publisher's policy of the journal at Sherpa UK for the submitted, accepted, and published articles. Click OAPolicy

Plan-S Compliance

To check compliance, one has to use the Journal Check Tool (JCT). This tool provided by cOAlition S (European funders) for the researchers (fundee) to check the compliance with the journal.

Recommend journal to your library

You can recommend the journal being a researcher or faculty member to your library. We will post a copy of the Journal to your library on your behalf at free of cost.
Click here: Recommend Journal

Preprint Arxiv Submission

The authors are encouraged to submit the author’s copy (preprint) to appropriate preprint archives e.g. https://arxiv.org and/or on https://indiarxiv.org or institutional repositories (e.g., D Space) before paper acceptance by the editor of Journal. After publications of the paper author(s) should mention the citation information, title and abstract along with DOI number of the publication carefully on the required page of the depository(ies).

Contact: Phone: +91-172-2741000, +91-172-4691800

Email : editor.jptrm@chitkara.edu.in;

Abstract and Indexing

Information

This work is licensed under a Creative Commons Attribution 4.0 International License.

Articles in Journal of Pharmaceutical Technology, Research and Management (J. Pharm. Tech. Res. Management) by Chitkara University Publications are Open Access articles that are published with licensed under a Creative Commons Attribution- CC-BY 4.0 International License. Based on a work at https://jptrm.chitkara.edu.in/. This license permits one to use, remix, tweak and reproduction in any medium, even commercially provided one give credit for the original creation.

View Legal Code of the above-mentioned license, https://creativecommons.org/licenses/by/4.0/legalcode

View Licence Deed here https://creativecommons.org/licenses/by/4.0/